Ratings by BofA Securities (Geoff Meacham)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/2/2021 Abbvie ABBV Maintain Neutral
(N/A)
 
 
  Details
7/28/2021 Pfizer PFE Maintain Neutral
(N/A)
 
 
  Details
7/26/2021 Acumen Pharmaceuticals, Inc. ABOS New Coverage Neutral
(N/A)
17.08
(15.27)
-10.6% Details
7/19/2021 Merck MRK Maintain Neutral
(N/A)
 
 
  Details
7/16/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
7/13/2021 Century Therapeutics IPSC New Coverage Buy
(N/A)
27.25
(29.23)
7.27% Details
7/12/2021 Lyell Immunopharma LYEL New Coverage Buy
(N/A)
15.88
(14.72)
-7.3% Details
7/6/2021 Janux Therapeutics JANX New Coverage Buy
(N/A)
25.40
(34.02)
33.94% Details
6/22/2021 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
6/15/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
6/8/2021 Merck MRK Maintain Neutral
(N/A)
 
 
  Details
6/7/2021 Biogen BIIB Upgrade Neutral
(Underperform)
286.14
(331.70)
15.92% Details
5/19/2021 Abbvie ABBV Maintain Neutral
(N/A)
 
 
  Details
4/30/2021 Merck MRK Maintain Neutral
(N/A)
 
 
  Details
4/30/2021 Bristol-Myers Squibb Co. BMY Maintain Buy
(N/A)
 
 
  Details
4/1/2021 BioXcel Therapeutics BTAI Maintain Buy
(N/A)
 
 
  Details
3/19/2021 Kiniksa KNSA Maintain Buy
(N/A)
 
 
  Details
3/17/2021 Bristol-Myers Squibb Co. BMY Maintain Buy
(N/A)
 
 
  Details
2/1/2021 Moderna MRNA Downgrade Underperform
(Neutral)
173.16
(346.61)
100.17% Details
1/26/2021 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
1/5/2021 Vertex VRTX Maintain Buy
(N/A)
 
 
  Details
1/5/2021 Regeneron Pharma REGN Maintain Neutral
(N/A)
 
 
  Details
1/5/2021 Rocket Pharmaceuticals RCKT Maintain Buy
(N/A)
 
 
  Details
1/5/2021 PMV Pharmaceuticals Inc. PMVP Maintain Buy
(N/A)
 
 
  Details
1/5/2021 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
1/5/2021 Kymera Therapeutics KYMR Maintain Neutral
(N/A)
 
 
  Details
1/5/2021 Genfit GNFT Maintain Underperform
(N/A)
 
 
  Details
1/5/2021 CRISPR Therapeutics CRSP Maintain Buy
(N/A)
 
 
  Details
1/5/2021 BridgeBio Pharma BBIO Maintain Neutral
(N/A)
 
 
  Details
1/5/2021 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
12/16/2020 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
12/11/2020 Abbvie ABBV Maintain Neutral
(N/A)
 
 
  Details
12/9/2020 Pfizer PFE Maintain Neutral
(N/A)
 
 
  Details
12/7/2020 Regeneron Pharma REGN Maintain Neutral
(N/A)
 
 
  Details
12/3/2020 Moderna MRNA Maintain Buy
(N/A)
 
 
  Details
11/17/2020 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
11/9/2020 Biogen BIIB Downgrade Underperform
(Neutral)
324.77
(286.14)
-11.89% Details
11/4/2020 Biogen BIIB Upgrade Neutral
(Underperform)
247.01
(331.70)
34.29% Details
10/29/2020 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
10/20/2020 Omeros Corp. OMER New Coverage Buy
(N/A)
11.08
(14.98)
35.2% Details
9/15/2020 Kymera Therapeutics KYMR New Coverage Neutral
(N/A)
32.78
(59.61)
81.85% Details
9/1/2020 Checkmate Pharmaceuticals CMPI New Coverage Neutral
(N/A)
15.58
(5.28)
-66.11% Details
8/19/2020 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
7/15/2020 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
6/25/2020 Regenxbio Inc. RGNX New Coverage Buy
(N/A)
35.31
(31.96)
-9.49% Details
6/25/2020 Genfit GNFT New Coverage Underperform
(N/A)
5.91
(3.84)
-35.03% Details
6/10/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
6/2/2020 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
6/2/2020 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
6/2/2020 Regeneron Pharma REGN Maintain Neutral
(N/A)
 
 
  Details
5/19/2020 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
5/15/2020 Bristol-Myers Squibb Co. BMY Maintain Buy
(N/A)
 
 
  Details
5/1/2020 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
4/29/2020 Merck MRK Maintain Neutral
(N/A)
 
 
  Details
3/5/2020 Amgen AMGN Upgrade Buy
(Neutral)
215.11
(239.79)
11.47% Details
12/11/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
11/22/2019 Amgen AMGN Maintain Neutral
(N/A)
 
 
  Details
11/20/2019 Vertex VRTX Maintain Buy
(N/A)
 
 
  Details
10/23/2019 Biogen BIIB Maintain Underperform
(N/A)
 
 
  Details